menu
    • menu

    Company profile for Renovacor

    NEW Drugs in Dev: 1
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Renovacor’s mission is to deliver innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. Our lead program is a recombinant adeno-associated virus (AAV9)‑based gene therapy for patients suffering from dilated cardiomyopathy (DCM) due to mutations in the Bcl2‑associated athanogene 3 (BAG3) gene. BAG3-associated DCM pat...
    Renovacor’s mission is to deliver innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. Our lead program is a recombinant adeno-associated virus (AAV9)‑based gene therapy for patients suffering from dilated cardiomyopathy (DCM) due to mutations in the Bcl2‑associated athanogene 3 (BAG3) gene. BAG3-associated DCM patients tend to be relatively young, with an average age at diagnosis of 37 years.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RenovacorUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Philadelphia, Pennsylvania
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://renovacor.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/renovacor/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/renovacor

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BD&L Summit

    BD&L Summit

    Not Confirmed

    envelop Contact Supplier

    BD&L Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rocket Pharmaceuticals Completes Acquisition of Renovacor
    Rocket Pharmaceuticals Completes Acquisition of Renovacor

    01 Dec 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221201005853/en

    BUSINESSWIRE
    01 Dec 2022
    Share Share
    Renovacor Announces Upcoming Presentation at the 29th European Society
    Renovacor Announces Upcoming Presentation at the 29th European Society

    10 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221010005557/en/Renovacor-Announces-Upcoming-Presentation-at-the-29th-European-Society-of-Gene-Cell-Therapy-Congress

    BUSINESSWIRE
    10 Oct 2022
    Share Share
    Renovacor Announces Upcoming Presentation at Keystone Symposia’s Heart Failure
    Renovacor Announces Upcoming Presentation at Keystone Symposia’s Heart Failure

    26 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220926005810/en

    BUSINESSWIRE
    26 Sep 2022
    Share Share
    Rocket Pharmaceuticals snaps up gene therapy startup Renovacor
    Rocket Pharmaceuticals snaps up gene therapy startup Renovacor

    21 Sep 2022

    // Nick Paul Taylor FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/rocket-inks-renovacor-buyout-land-heart-disease-gene-therapy

    Nick Paul Taylor FIERCEBIOTECH
    21 Sep 2022
    Share Share
    Rocket Fuels AAV Cardiac Portfolio with Renovacor Buy
    Rocket Fuels AAV Cardiac Portfolio with Renovacor Buy

    20 Sep 2022

    // BIOSPACE

    https://www.biospace.com/article/rocket-pharmaceuticals-acquires-renovacor-in-allstock-deal/?s=79

    BIOSPACE
    20 Sep 2022
    Share Share
    Renovacor Reports Second Quarter 2022 Financial Results
    Renovacor Reports Second Quarter 2022 Financial Results

    08 Aug 2022

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20220808005772/en

    BUSINESS WIRE
    08 Aug 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search